Literature DB >> 9625350

Transient neutropenia may be a risk of treating preterm neonates with high doses of recombinant erythropoietin.

G Latini, E Rosati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625350     DOI: 10.1007/pl00008288

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  Erythropoietin affects the maturation pattern of fetal G-CSF-responsive progenitors.

Authors:  R D Christensen; G Rothstein
Journal:  Am J Hematol       Date:  1992-02       Impact factor: 10.047

2.  Administration of erythropoietin to newborn rats results in diminished neutrophil production.

Authors:  R D Christensen; K W Liechty; J M Koenig; K R Schibler; R K Ohls
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

3.  Blood transfusions and human recombinant erythropoietin in premature newborn infants.

Authors:  P Williamson; G Griffiths; D Norfolk; M Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

4.  The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.

Authors:  R F Maier; M Obladen; P Scigalla; O Linderkamp; G Duc; G Hieronimi; H L Halliday; H T Versmold; G Moriette; G Jorch
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

5.  Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.

Authors:  K M Shannon; J F Keith; W C Mentzer; R A Ehrenkranz; M S Brown; J A Widness; C A Gleason; E M Bifano; D D Millard; C B Davis
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124

  5 in total
  1 in total

1.  Late-onset neutropenia: defining limits of neutrophil count in very low birth weight infants.

Authors:  S Vetter-Laracy; P-R Balliu; J A Salinas; M A Duran
Journal:  J Perinatol       Date:  2013-09-12       Impact factor: 2.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.